PROLONGED DISEASE-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA WITH A POOR PROGNOSIS

被引：314

作者：

TAKVORIAN, T

CANELLOS, GP

RITZ, J

FREEDMAN, AS

ANDERSON, KC

MAUCH, P

TARBELL, N

CORAL, F

DALEY, H

YEAP, B

SCHLOSSMAN, SF

NADLER, LM

机构：

[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA

[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV RADIAT THERAPY, BOSTON, MA 02115 USA

[3] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV BIOSTAT, BOSTON, MA 02115 USA

[4] BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA

[5] BRIGHAM & WOMENS HOSP, DEPT RADIAT THERAPY, BOSTON, MA 02115 USA

[6] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1987年 / 316卷 / 24期

关键词：

D O I：

10.1056/NEJM198706113162402

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1499 / 1505

页数：7

共 53 条

[1] HISTOLOGIC CONVERSION IN THE NON-HODGKINS LYMPHOMAS [J].

ACKER, B ;

HOPPE, RT ;

COLBY, TV ;

COX, RS ;

KAPLAN, HS ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (01) :11-16

[2]

ANDERSON KC, 1987, BLOOD, V69, P597

[3]

ANDERSON T, 1982, CANCER-AM CANCER SOC, V50, P2708, DOI 10.1002/1097-0142(19821215)50:12<2708::AID-CNCR2820501203>3.0.CO

[4]

2-G

[5]

Appelbaum F R, 1983, Hematol Oncol, V1, P149

[6] REVIEW OF THE USE OF MARROW TRANSPLANTATION IN THE TREATMENT OF NON-HODGKINS LYMPHOMA [J].

APPELBAUM, FR ;

THOMAS, ED .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (07) :440-447

[7]

APPELBAUM FR, IN PRESS J CLIN ONCO

[8]

ARMITAGE JO, 1986, LANCET, V2, P960

[9]

ARMITAGE JO, 1981, CANCER TREAT REP, V65, P413

[10]

ARMITAGE JO, 1986, CANCER TREAT REP, V70, P871

← 1 2 3 4 5 6 →